Incanthera
Goal Group
  • About us
    • What we do
    • Our strategy
    • Market opportunity
    • Our team
    • Our History
    • Origins – Institute of Cancer Therapeutics (ICT) Bradford
  • Pipeline
    • Our products
    • For patients
  • Partnering
    • Our partnerships
  • Investors
    • Overview
    • Why invest?
    • IPO materials
    • Regulatory news
    • Results, Reports and Presentations
    • Research Notes
    • Email alerts
    • Share price and tools
    • Financial calendar
    • Shareholder information
    • Investor and Advisor contacts
    • AQSE Growth Market Rule 4.14
    • Corporate Governance
    • Company Contact Details
  • News & media
    • News
    • Press Coverage
    • Scientific Publications
  • Contact Us
  • Sustainability
Share price INC 05.75 GBp
  • About us
    • What we do
    • Our strategy
    • Market opportunity
    • Our team
      • Board of Directors
      • Senior Management
      • Advisors and Founders
    • Our History
    • Origins – Institute of Cancer Therapeutics (ICT) Bradford
  • Pipeline
    • Our products
    • For patients
  • Partnering
    • Our partnerships
  • Investors
    • Overview
    • Why invest?
    • IPO materials
    • Regulatory news
    • Results, Reports and Presentations
    • Research Notes
    • Email alerts
    • Share price and tools
      • Share price chart
      • Detailed share price
    • Financial calendar
    • Shareholder information
      • Shareholder Information
      • AGM
      • GM
      • Analyst coverage
    • Investor and Advisor contacts
    • AQSE Growth Market Rule 4.14
    • Corporate Governance
      • Corporate Governance Report
      • QCA Corporate Governance Principles
    • Company Contact Details
  • News & media
    • News
    • Press Coverage
    • Scientific Publications
  • Contact Us
  • Sustainability

News

  • Home
  • News & media
  • News
  • News
  • Press Coverage
  • Scientific Publications

Latest from Incanthera

News

  • 2025
  • 2024
  • 2023
  • Archive
April 1st, 2025 Extension of Warrants and Debt Conversion and Issue of Equity
March 28th, 2025 Commercial Update
March 25th, 2025 Successful Resolution of Allegations of Patent Infringement
  • Incanthera
  • Incanthera
  • Incanthera
  • Incanthera
  • Incanthera
  • Incanthera
Sign up for email alerts Register your email

This website uses cookies. By continuing to access the site you are agreeing to their use. Learn more about cookies.

  • © 2025 Incanthera plc

  • Sitemap
  • Contact Us
  • Privacy Policy

By  emperor